Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 12
Submit an article Journal homepage
273
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Prolonged progression-free survival and preserved quality of life in the Canadian prospective study of tositumomab and iodine131-tositumomab for previously treated, rituximab-exposed, indolent non-Hodgkin lymphoma

Harold J. OlneyCentre Hospitalier de l’Université de Montréal, Montreal, CanadaCorrespondence[email protected]
,
Marni A. FreemanGlaxoSmithKline Inc., Mississauga, Canada
,
Douglas A. StewartUniversity of Calgary and Tom Baker Cancer Centre, Calgary, Canada
,
Joy E. MangelLondon Health Sciences Centre, London, Canada
,
Darrell J. WhiteQEII Health Sciences Centre, Halifax, Canada
&
Julia O. Elia-PacittiGlaxoSmithKline Inc., Mississauga, Canada
Pages 2754-2760 | Received 11 Nov 2013, Accepted 07 Feb 2014, Published online: 03 Apr 2014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.